Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 3/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16612790 | 0.86 | HCRTR2 (0.39) | HCRTR2HTR1ASLC6A4LMNACXCR3 | |
| SCHEMBL16612954 | 0.81 | LMNA (0.53) | LMNA | |
| SCHEMBL16612613 | 0.78 | MTNR1A (0.49) | HCRTR2LMNA | |
| SCHEMBL16612876 | 0.77 | HTR2C (0.41) | HCRTR2HTR1ASLC6A4LMNAAR | |
| SCHEMBL16613000 | 0.75 | HTR2A (0.42) | HCRTR2LMNAFABP4 | |
| SCHEMBL16612920 | 0.74 | CDK4 (0.52) | LMNA | |
| SCHEMBL16612871 | 0.74 | HCRTR2 (0.36) | HCRTR2CXCR3 | |
| SCHEMBL16612745 | 0.74 | HDAC6 (0.42) | HCRTR2LMNACXCR3 | |
| SCHEMBL12480072 | 0.73 | HTR2A (0.41) | HCRTR2LMNA | |
| SCHEMBL16612704 | 0.71 | MET (0.41) | HCRTR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2675801-B1 | NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2015-04-08 | — | — | EP | claimed |